Overview

Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer

Status:
Terminated
Trial end date:
2016-10-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to test the role of cycline in the prevention of acne-like skin rash in metastatic colorectal patients treated with Cetuximab and intensified FOLFIRI.
Phase:
N/A
Details
Lead Sponsor:
ICO Paul Papin
Institut Cancerologie de l'Ouest
Treatments:
Cetuximab
Doxycycline